Olanzapine Tablet, Orally Disintegrating
Product Images NDC 65862-656

5 FDA label images from Aurobindo Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 65862-656). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (5 mg Blister Carton (3 x 10 Tablets))

Package Label-principal Display Panel (5 mg Blister Carton (3 x 10 Tablets))
Package label for Olanzapine Orally Disintegrating Tablets USP 5 mg, showing a 30 tablet unit-dose pack (3 x 10). The label includes storage instructions, dosage warnings, and phenylketonurics information. Labeler is Aurobindo Pharma Limited, with distribution by Aurobindo Pharma USA, Inc.*
FDA Label Image

Package Label-principal Display Panel (10 mg Blister Carton (3 x 10 Tablets))

Package Label-principal Display Panel (10 mg Blister Carton (3 x 10 Tablets))
Packaging label for Olanzapine Orally Disintegrating Tablets USP 10 mg by Aurobindo Pharma Limited. The label shows a unit-dose package containing 30 tablets (3 x 10). It includes storage instructions, a barcode, and a note for pharmacists to dispense the accompanying medication guide.*
FDA Label Image

Package Label-principal Display Panel (15 mg Blister Carton (3 x 10 Tablets))

Package Label-principal Display Panel (15 mg Blister Carton (3 x 10 Tablets))
Packaging label for Olanzapine Orally Disintegrating Tablets USP 15 mg by Aurobindo Pharma Limited. The label states a unit-dose package of 30 tablets (3 x 10) with dosage form orally disintegrating tablets. It includes storage instructions and a barcode. Distributed by Aurobindo Pharma USA, Inc., made in India.*
FDA Label Image

Package Label-principal Display Panel (20 mg Blister Carton (3 x 10 Tablets))

Package Label-principal Display Panel (20 mg Blister Carton (3 x 10 Tablets))
Label for Olanzapine Orally Disintegrating Tablets USP 20 mg, a drug for further processing. The packaging specifies 30 unit-dose tablets (3 x 10). The label includes dosage instructions, storage conditions, a barcode, and distributor information for Aurobindo Pharma USA, Inc. The label warns that the package is not child resistant and instructs pharmacists to dispense the medication guide.*
FDA Label Image

Chemical Structure (Olanzapine Str)

Chemical Structure (Olanzapine Str)
Chemical structure diagram of Olanzapine, showing its molecular framework with heterocyclic rings and substituents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.